Investor directory

UCeed

UCeed, established in 2020 and headquartered in Calgary, Canada, is a venture capital firm managed by Innovate Calgary. It focuses on investing in early-stage, pre-seed and seed-stage companies, primarily in the technology, healthcare, and software sectors. UCeed's mission is to support promising startups, bridging the gap between innovation and commercialization by providing critical early-stage funding.
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://signal.nfx.com/firms/***

Jehangir Appoo MD

Director, Health Venture Capital Fund

William Szczepaniak

Managing Director

Past deals in Alberta

True Angle

Seed Round in 2023
True Angle is an Alberta-based medical technology company located in Edmonton, Canada, focused on improving the quality of life for individuals with swallowing disorders. The company has developed the Mobili-T, a mobile device that enables users to perform necessary exercises at home, enhancing their ability to eat safely. This innovative solution is supported by an engaging app that tracks muscle contractions and provides feedback, guiding users to meet specific rehabilitation targets set by the device's smart software. In addition to addressing swallowing difficulties, True Angle aims to support remote care delivery solutions that contribute to overall well-being, particularly as individuals age.

PulseMedica

Seed Round in 2023
PulseMedica is a medical device company based in Edmonton. It develops non-invasive, automated image-guided laser treatments for vitreoretinal diseases using 3D computer vision and femtosecond laser technology.

PulseMedica

Seed Round in 2022
PulseMedica is a medical device company based in Edmonton. It develops non-invasive, automated image-guided laser treatments for vitreoretinal diseases using 3D computer vision and femtosecond laser technology.

PulseMedica

Seed Round in 2021
PulseMedica is a medical device company based in Edmonton. It develops non-invasive, automated image-guided laser treatments for vitreoretinal diseases using 3D computer vision and femtosecond laser technology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.